{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:10:41Z","timestamp":1793725841159,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jhep.2023.03.040","type":"journal-article","created":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T09:34:43Z","timestamp":1681032883000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":306,"title":["Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5051-3160","authenticated-orcid":false,"given":"Michael H.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Baez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-3649","authenticated-orcid":false,"given":"KeeSeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8232-3994","authenticated-orcid":false,"given":"Christopher D.","family":"Stave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6275-4989","authenticated-orcid":false,"given":"Mindie H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jhep.2023.03.040_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.03.040_bib2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2023.03.040_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.03.040_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"10.1016\/j.jhep.2023.03.040_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.13035","article-title":"Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016","volume":"287","author":"Le","year":"2020","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.jhep.2023.03.040_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.03.040_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2016.0109","article-title":"Genetic predisposition in nonalcoholic fatty liver disease","volume":"23","author":"Sookoian","year":"2017","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.03.040_bib13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jhep.2023.03.040_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.dld.2012.05.006","article-title":"PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals","volume":"44","author":"Burza","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"12","key":"10.1016\/j.jhep.2023.03.040_bib15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.jhep.2023.03.040_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1665-2681(19)31253-0","article-title":"Survey of health status, nutrition and geography of food selection of chronic liver disease patients","volume":"13","author":"Leslie","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2023.03.040_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32427","article-title":"Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles","author":"Mart\u00ednez-Arranz","year":"2022","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jhep.2023.03.040_bib18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jhep.2023.03.040_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/clinem\/dgab578","article-title":"The emerging role of glucagon-like peptide-1 receptor agonists for the management of NAFLD","volume":"107","author":"Patel Chavez","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jhep.2023.03.040_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.jhep.2023.03.040_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.03.040_bib22","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","author":"Le","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2023.03.040_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.03.040_bib24","series-title":"The most recent and in-depth meta-analytic assessment of the global epidemiology of nonalcoholic fatty liver disease (NAFLD)","author":"Younossi","year":"2022"},{"issue":"18","key":"10.1016\/j.jhep.2023.03.040_bib25","first-page":"32121","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","author":"Estes","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.03.040_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030","volume":"24","author":"Alswat","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.03.040_bib27","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2019.20152","article-title":"Nonalcoholic fatty liver disease burden - Switzerland 2018-2030","volume":"149","author":"Goossens","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"10.1016\/j.jhep.2023.03.040_bib28","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.9778\/cmajo.20190212","article-title":"Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study","volume":"8","author":"Swain","year":"2020","journal-title":"CMAJ Open"},{"issue":"9","key":"10.1016\/j.jhep.2023.03.040_bib29","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/jgh.15009","article-title":"Nonalcoholic fatty liver disease burden: Australia, 2019-2030","volume":"35","author":"Adams","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.03.040_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of nonalcoholic fatty liver disease in Asia, the Middle East and North Africa: data from global burden of disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.03.040_bib31","unstructured":"Wells GA, Shea B, Peterson J, et\u00a0al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed September 8,\u00a02021."},{"key":"10.1016\/j.jhep.2023.03.040_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"10.1016\/j.jhep.2023.03.040_bib33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/liv.13332","article-title":"The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease","volume":"37","author":"Kwak","year":"2017","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhep.2023.03.040_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12603-017-0967-3","article-title":"Smoking predicting physical activity in an aging America","volume":"22","author":"Swan","year":"2018","journal-title":"J\u00a0Nutr Health Aging"},{"issue":"6","key":"10.1016\/j.jhep.2023.03.040_bib35","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/ijerph16060974","article-title":"Smoking and physical activity trajectories from childhood to midlife","volume":"16","author":"Salin","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.jhep.2023.03.040_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.jhep.2023.03.040_bib37","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Nonalcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jhep.2023.03.040_bib38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2023.03.040_bib39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A\u00a0global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1 Pt 1","key":"10.1016\/j.jhep.2023.03.040_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jfma.2019.03.014","article-title":"Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis","volume":"119","author":"Huang","year":"2020","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"12","key":"10.1016\/j.jhep.2023.03.040_bib41","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00535-018-1472-0","article-title":"Hepatic IRS1 and \u00df-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients","volume":"53","author":"Enooku","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"issue":"10","key":"10.1016\/j.jhep.2023.03.040_bib42","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/liv.13739","article-title":"Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease","volume":"38","author":"Bertot","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.03.040_bib43","unstructured":"https:\/\/www.who.int\/health-topics\/diabetes#tab=tab_1."},{"key":"10.1016\/j.jhep.2023.03.040_bib44","unstructured":"https:\/\/www.who.int\/health-topics\/obesity#tab=tab_1."},{"issue":"5","key":"10.1016\/j.jhep.2023.03.040_bib45","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2023.03.040_bib46","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2023.03.040_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12072-020-10023-3","article-title":"The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis","volume":"14","author":"Wu","year":"2020","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.jhep.2023.03.040_bib47","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1159\/000514953","article-title":"NASH\/Liver fibrosis\u00a0prevalence and incidence of nonliver comorbidities among people\u00a0with NAFLD and incidence of NAFLD by metabolic comorbidities: lessons from South Korea","volume":"39","author":"Park","year":"2021","journal-title":"Dig Dis"},{"issue":"9796","key":"10.1016\/j.jhep.2023.03.040_bib48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(11)61055-6","article-title":"What has made the population of Japan healthy?","volume":"378","author":"Ikeda","year":"2011","journal-title":"Lancet"},{"issue":"9798","key":"10.1016\/j.jhep.2023.03.040_bib49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61220-8","article-title":"The value of the national health and nutrition survey in Japan","volume":"378","author":"Sasaki","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jhep.2023.03.040_bib52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.03.040_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","article-title":"Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD","volume":"18","author":"Tamaki","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.jhep.2023.03.040_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.03.040_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"NAFLD Consensus Consortium. Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.03.040_bib55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823002192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823002192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:49:34Z","timestamp":1759175374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823002192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0168827823002192"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.03.040","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}